1 completed. 1 Early Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Early Phase 1 | 1 | Completed 1 |
Follow Transplant-Related Hematologic Malignancy: new trials by email Literature Review of Transplant-Related Hematologic Malignancy trials Research Report on Transplant-Related Hematologic Malignancy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Immunotherapy With Tacrolimus Resistant EBV CTL for Lymphoproliferative Disease After Solid Organ Transplant Autologous EBV-CTL transduced with vector SFG-CNA12, Autologous EBV-CTL transduced with control vector SFG-CNA8, Leucapheresis - Post-transplant Lymphoproliferative Disease, Transplant-Related Hematologic Malignancy | Early Phase 1 | Completed | University College, London | 4 | 2019-05-31 | 2026-08-07 |
Leukapheresis (1)
University College, London (1)
United Kingdom (1)